GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $50,000 | -99.9% | 235 | -56.1% | 0.00% | -100.0% |
| Q4 2020 | $34,650,000 | +18.6% | 535 | 0.0% | 0.10% | +630.8% |
| Q3 2020 | $29,227,000 | -20.7% | 535 | 0.0% | 0.01% | -40.9% |
| Q2 2020 | $36,844,000 | +40.1% | 535 | 0.0% | 0.02% | +22.2% |
| Q1 2020 | $26,291,000 | +62497.6% | 535 | +118.4% | 0.02% | – |
| Q2 2019 | $42,000 | -99.8% | 245 | +4.3% | 0.00% | -100.0% |
| Q4 2018 | $22,886,000 | -41.8% | 235 | 0.0% | 0.01% | -38.5% |
| Q3 2018 | $39,306,000 | +18.8% | 235 | 0.0% | 0.01% | +8.3% |
| Q2 2018 | $33,083,000 | +33.0% | 235 | 0.0% | 0.01% | -14.3% |
| Q1 2018 | $24,877,000 | -19.5% | 235 | 0.0% | 0.01% | -17.6% |
| Q4 2017 | $30,902,000 | -1.1% | 235 | -17.5% | 0.02% | -10.5% |
| Q3 2017 | $31,244,000 | -6.8% | 285 | -14.9% | 0.02% | -13.6% |
| Q2 2017 | $33,533,000 | +0.5% | 335 | +17.5% | 0.02% | +37.5% |
| Q1 2017 | $33,371,000 | +19.3% | 285 | +21.3% | 0.02% | -15.8% |
| Q4 2016 | $27,979,000 | – | 235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |